Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Drug Resistance, Bacterial drug effects MeSH
- Bifidobacterium drug effects growth & development MeSH
- Humans MeSH
- Milk, Human drug effects microbiology MeSH
- Microbial Sensitivity Tests MeSH
- Muramidase pharmacology MeSH
- Infant, Newborn MeSH
- Probiotics * MeSH
- Check Tag
- Humans MeSH
- Infant, Newborn MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- hen egg lysozyme MeSH Browser
- Muramidase MeSH
Resistance or susceptibility of bifidobacteria to lysozyme and growth of bifidobacteria in human milk were tested. Susceptible bifidobacterial strains stopped their growth almost immediately after the addition of lysozyme (400 microg/ml), moderately susceptible strains exhibited reduced growth rate, and growth curves of resistant strains were not affected. Strains of human origin were more resistant to lysozyme than animal strains. While strains of B. bifidum grew well in human milk samples, the growth B. animalis strains was inhibited after inoculation to human milk. The resistance to lysozyme seems to be a promising criterion for the selection of new probiotic bifidobacterial strains.
References provided by Crossref.org
Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides
